Hudson Bay Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Hudson Bay Capital Management’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-716	Closed	-$57K	–	1439
2022 Q1	$57K	Sell	716 -1,209	-63%	-$149K	﹤0.01%	1002
2021 Q4	$392K	Sell	1,925 -8,075	-81%	-$2.01M	﹤0.01%	871
2021 Q3	$3M	Buy	+10,000	New	+$2.92M	0.04%	523
2020 Q3	–	Sell	-2,000	Closed	-$398K	–	649
2020 Q2	$398K	Buy	+2,000	New	+$396K	0.01%	415

Other funds holding VINC

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Hudson Bay Capital Management's VINC Position: Q2 2022 in Review

Hudson Bay Capital Management sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2022, closing a stake of 716 shares — an estimated $57K sold.

Hudson Bay Capital Management first reported a position in VINC in Q2 2020 and held it in 4 quarters. The position peaked at $3M in Q3 2021. 51 funds tracked by Wall St. Rank hold VINC as of Q2 2022.

Hudson Bay Capital Management reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Hudson Bay Capital Management sold 716 Vincerx Pharma, Inc. Common Stock shares in Q2 2022, an estimated $57K.
Hudson Bay Capital Management first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
Hudson Bay Capital Management's Vincerx Pharma, Inc. Common Stock position peaked at $3M in Q3 2021.
51 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2022.

Based on Hudson Bay Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.